These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3931338)

  • 1. Gold-induced immune thrombocytopenia in the dog.
    Bloom JC; Blackmer SA; Bugelski PJ; Sowinski JM; Saunders LZ
    Vet Pathol; 1985 Sep; 22(5):492-9. PubMed ID: 3931338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative safety and efficacy of auranofin and parenteral gold compounds: a review.
    Horton RJ
    Scand J Rheumatol Suppl; 1983; 51():100-10. PubMed ID: 6426044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the kinetics of parenteral and oral gold.
    Gottlieb NL
    Scand J Rheumatol Suppl; 1983; 51():10-4. PubMed ID: 6426043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1980; 7(6):820-4. PubMed ID: 6782245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of oral and injectable gold compounds.
    Blocka KL; Paulus HE; Furst DE
    Clin Pharmacokinet; 1986; 11(2):133-43. PubMed ID: 3082559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 9. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 10. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 11. An oral gold formulation in rheumatoid arthritis. A 12-month follow-up report.
    Schorn D
    S Afr Med J; 1982 Aug; 62(10):313-6. PubMed ID: 6810477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in gold-treated rheumatoid arthritis.
    Katz WA; Blodgett RC; Pietrusko RG
    Ann Intern Med; 1984 Aug; 101(2):176-9. PubMed ID: 6430141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold induced thrombocytopenia: 12 cases and a review of the literature.
    Adachi JD; Bensen WG; Kassam Y; Powers PJ; Bianchi FA; Cividino A; Kean WF; Rooney PJ; Craig GL; Buchanan WW
    Semin Arthritis Rheum; 1987 May; 16(4):287-93. PubMed ID: 3110956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter double-blind comparison of auranofin and Tauredon].
    Kaik B; Bröll H
    Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic actions and pharmacokinetic studies of auranofin.
    Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
    Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auranofin.
    Davis P
    Clin Rheum Dis; 1984 Aug; 10(2):369-83. PubMed ID: 6239742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open comparative study of auranofin vs. gold sodium thiomalate.
    Smith PR; Brown GM; Meyers OL
    J Rheumatol Suppl; 1982; 8():190-6. PubMed ID: 6813484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.